In this study, we predicted that TGFBR2 is a target of miR-135b, a miRNA that has been reported in many studies to be upregulated and to function as an oncogenic unit in CRC [21,32,37,38]. The gene discussed is TGFBR2; the disease is colorectal carcinoma.